Frost + Sullivan Issue Independent Report on Optisol Solar Concentrator Technology

Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB:INKN) (OTCBB:INKND), an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that Frost & Sullivan's Technology Insights has issued an independent report entitled “Nanotech Technology Alert” on the OptiSol™ Solar Concentrator technology, a proprietary and disruptive nanotechnology-based solar energy concentrator that is being commercialized by wholly-owned subsidiary Shrink Solar LLC, an operating subsidiary of Shrink Nanotechnologies, Inc.

According to Technology Insights, “The OptiSol solar concentrator offers a number of advantages. Concentrating solar power systems typically use mirrors, lenses and tracking devices to focus sunlight onto a small photovoltaic device. The OptiSol concentrator however does not employ any of these optical elements. It acts more like a fiberoptic 'sheet,' trapping and guiding sunlight to a side-mounted PV cell. Since this design can be achieved using plastic rather than glass, the devices tend to be low-cost, lightweight and durable. While the other competing technologies use short-lived fluorescent dyes; and the materials used in this concentrator have very desirable life spans.”

The article highlighted the technology's diverse applications, “The major application of the concentrator would be in functionalizing nearly every exterior surface of a home or building. The roof, windows, doors, siding, and so on, can all be transformed into power generators, with minimal aesthetic impact. Smaller scale applications would cater to consumer electronics, military devices and recreational markets.”


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.